was successfully added to your cart.

Your SEO optimized title page contents

For the cannabis community, Tuesday’s midterm elections ended in celebration. Three out of four battleground states for cannabis reform were victorious in changing legislation: Washington D.C., Oregon, and Alaska all legalized recreational use by adults. With a count of 58 for, and 42 against, Florida missed the 60 percent supermajority requirement to amend their constitution to include a medical cannabis program.

Florida, which has a considerable elderly demographic and a population of over 19 million, would have been one of the largest markets for medical marijuana. Many supporters of Amendment 2, Florida Right to Medical Marijuana Initiative, feel that deceptive and last minute TV advertisements by the opposition led to this year’s marginal loss. One concern heard by many opposing the amendment in polling stations this Tuesday was that the Amendment was too loosely worded raising fear that children would be able to acquire cannabis. Either way, the Sunshine State’s initiative for medical marijuana was one of the most expensive measures in the country, with both the opposition and support campaigns spending over $6.5 million each.

For all the budding entrepreneurs in the state, this fight is far from over: a 58 percent approval is a clear indication that the paradigm through which Americans view cannabis is changing. The first sign of progress in Florida came in July: Governor Rick Scott signed a highly restrictive bill giving patients with life-threatening illnesses access to low THC, high CBD extracts. The measure only applies to patients for whom conventional methods of treatment have failed, and all other options have been exhausted. This law allows for five dispensing facilities to grow, process, and dispense these cannabidiol extracts for the entire state of Florida.

Tracing the history of medical marijuana shows that one vote no is not enough to stop the movement. Looking at Colorado’s history is example enough: in 1998 Colorado’s Amendment 19 was the first medical marijuana initiative introduced in the state, and it did not pass. It wasn’t until two years later that Amendment 20, the new medical cannabis initiative, was placed on the ballot and won: 54 percent to 46 percent.

Though the medical marijuana initiative did not pass this year’s midterm vote, there are many reasons to be optimistic: sentiments towards both medical and recreational uses of cannabis have never been higher. Even conservative outlets such as Fox News report that 85 percent of Americans believe adults should be allowed to use cannabis for medical purposes.

If you are interested in new licensing opportunities in Oregon, Alaska, or existing medical and retail states, our business analysts at Quantum 9 are the foremost experts in the field. If you would like to know about our predictions for the next emerging markets or how our consulting services can help you get the licensing you need, don’t hesitate- contact us today!

About Michael Mayes

As Chief Executive Officer for Quantum 9, Inc., Michael has assisted in funding some of the largest commercial cannabis projects in the world. Michael has been a cannabis investor since 2009 in Colorado’s first legal for-profit cannabis market. As the co-founder and CEO of Quantum 9, Inc., Michael has spent years designing technology and collaborating with countless consultants on the forefront of the cannabis industry. Collaborating with the brightest minds and contributing to world-class organizations has been an incredibly enlightening and rewarding experience for him. Also, he has amassed a comprehensive and award-winning team engaged globally for public policy best practices through the prioritization of environmental sustainability and patient care. Michael is a member of the International Cannabinoid Research Society (ICRS), contributor to Marijuana Business Daily, quoted in the Chicago Tribune, Tampa Tribune, Yahoo Finance, Tampa Tribune, Sativa Magazine, CBC and the Daily Herald. His media appearances include several CBS and WGN appearances and international presence on BNN Commodities in Canada. On the public policy front, Michael and his team were instrumental in their work of drafting the Kentucky Medical Marijuana Bill for Senator Perry Clark. Most recently, Michael taught a class for the International Pharmaceutical Academy in Toronto, Canada. He spoke on Cannabis Pharmacology, and the effects cannabis has on the endocannabinoid system.

Leave a Reply